Linear chain PEGylated recombinant Bacillus Thiaminolyticus thiaminase I enzyme has growth inhibitory activity against lymphoid leukemia cell lines

Molecular Cancer Therapeutics

Volumn 10, Issue 9, 2011, Pages 1563-1570

  Daily, Abigail ^a   Liu, Shuqian ^a   Bae, Younsoo ^b   Bhatnagar, Saloni ^a   Moscow, Jeffrey A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; CYTARABINE; DOXORUBICIN; LINEAR CHAIN PEGYLATED THIAMINASE I ENZYME; METHOTREXATE; RAPAMYCIN; THIAMINE; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURVIVAL; CYTOTOXICITY; FEMALE; HUMAN; IMMUNOBLOTTING; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BACILLUS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HL-60 CELLS; HUMANS; HYDROLASES; JURKAT CELLS; LEUKEMIA, LYMPHOID; MICE; MICE, NUDE; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; THIAMINE; TOR SERINE-THREONINE KINASES; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052770918     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-11-0003     Document Type: Article

References (13)

1. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.
2. Liu S, Huang H, Lu X, Golinski M, Comesse S, Watt D, et al. Downregulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol Cancer Res 2003;1:665-73. (Pubitemid 36870519)
3. Liu S, Stromberg A, Tai HH, Moscow JA. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. Mol Cancer Res 2004;2:477-87. (Pubitemid 39121510)
4. Liu S, Monks NR, Hanes JW, Begley TP, Yu H, Moscow JA. Sensitivity of breast cancer cell lines to recombinant thiaminase I. Cancer Chemother Pharmacol 2010;66:171-9.
5. Costello CA, Kelleher NL, Abe M, McLafferty FW, Begley TP. Mechanistic studies on thiaminase I. Overexpression and identification of the active site nucleophile. J Biol Chem 1996;271:3445-52. (Pubitemid 26065651)
6. Lu J, Frank EL. Rapid HPLC measurement of thiamine and its phosphate esters in whole blood. Clin Chem 2008;54:901-6. (Pubitemid 351671604)
7. Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006;6:813-23. (Pubitemid 44450469)
8. Fischer PM. Cap in hand: targeting eIF4E. Cell Cycle 2009;8:2535-41.
9. Ganapathy V, Smith SB, Prasad PD. SLC19: the folate/thiamine transporter family. Pflugers Arch 2004;447:641-6. (Pubitemid 38241449)
10. Richardson AD, Moscow JA. Can an enzyme cofactor be a factor in malignant progression? Cancer Biol Ther 2010;10:32-4.
11. Menon S, Manning BD. Common corruption of the mTOR signaling network in human tumors. Oncogene 2008;27 Suppl 2:S43-51.
12. Zhao F, Mancuso A, Bui TV, Tong X, Gruber JJ, Swider CR, et al. Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene 2010;29:2962-72.
13. Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 1948;238:787-93.